Compounders Argue US FDA’s GLP-1 Green List Validates Legit Practices

 
• By Aakash Babu
  
The green list would not restrict compounding by state-licensed pharmacies. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Manufacturing

More from United States